Mortalidad por infarto del miocardio en Chile: Trombolíticos o angioplastía / Acute myocardial infarction mortality in Chile: Thrombolysis or angioplasty
Rev. méd. Chile
;
139(11): 1393-1395, nov. 2011.
Article
in Spanish
| LILACS
| ID: lil-627567
ABSTRACT
During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and 5 to 6 % for patients treated with angioplasty. The decrease in mortality in Chile is related to the implementation of the AUGE program at a national level, initiative than gives patients the opportunity to receive at least thrombolytic therapy as well as a standardized and rapid diagnosis and treatment for this condition. There is a lack of Outcome Research studies in Chile, that would guide public health decisions such as the use of fibrin-specific agents for early presentation and high risk cases, and a rational system providing better access to primary angioplasty.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Thrombolytic Therapy
/
Angioplasty
/
Myocardial Infarction
/
National Health Programs
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2011
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Clínica Las Condes+CL
Similar
MEDLINE
...
LILACS
LIS